(Q50525310)

14 March 2018

title

Latent alpha1-antichymotrypsin. A molecular explanation for the inactivation of alpha1-antichymotrypsin in chronic bronchitis and emphysema (English)

1 reference

14 March 2018

1 reference

Chang WS

1 reference

14 March 2018

Lomas DA

series ordinal

1 reference

14 March 2018

language of work or name

English

0 references

publication date

1 February 1998

1 reference

14 March 2018

Journal of Biological Chemistry

published in

1 reference

14 March 2018

volume

273

1 reference

14 March 2018

issue

1 reference

14 March 2018

page(s)

3695-3701

1 reference

14 March 2018

Human plasma proteinase inhibitors

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.6.3695

Human alpha-1-antichymotrypsin: interaction with chymotrypsin-like proteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.6.3695

On the size of the active site in proteases. I. Papain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.6.3695

Human alpha 1-proteinase inhibitor. Crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.6.3695

Crystal structure of cleaved human alpha 1-antichymotrypsin at 2.7 A resolution and its comparison with other serpins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.6.3695

Structural basis of latency in plasminogen activator inhibitor-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.6.3695

Synthesis of pppGpN typs dinucleotide derivatives: the 5′ end sequence of some RNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.6.3695

Preparative induction and characterization of L-antithrombin: a structural homologue of latent plasminogen activator inhibitor-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.6.3695

Purification of active human plasminogen activator inhibitor 1 from Escherichia coli. Comparison with natural and recombinant forms purified from eucaryotic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.6.3695

Human α-1-antichymotrypsin: purification and properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.6.3695

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.6.3695

Probing serpin reactive-loop conformations by proteolytic cleavage

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.6.3695

alpha 1-Antitrypsin Mmalton (Phe52-deleted) forms loop-sheet polymers in vivo. Evidence for the C sheet mechanism of polymerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.6.3695

The 2.6 A structure of antithrombin indicates a conformational change at the heparin binding site

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.6.3695

Engineering of plasminogen activator inhibitor-1 to reduce the rate of latency transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.6.3695

Implications of the three-dimensional structure of alpha 1-antitrypsin for structure and function of serpins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.6.3695

Stimulatory effect of inflammatory cytokines on alpha 1-antichymotrypsin expression in human lung-derived epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.6.3695

Crystal structure of an uncleaved serpin reveals the conformation of an inhibitory reactive loop

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.6.3695

Type-1 inhibitor of plasminogen activators. Distinction between latent, activated and reactive centre-cleaved forms with thermal stability and monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.6.3695

Preparation and characterization of latent alpha 1-antitrypsin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.6.3695

Analysis of the plasma elimination kinetics and conformational stabilities of native, proteinase-complexed, and reactive site cleaved serpins: comparison of alpha 1-proteinase inhibitor, alpha 1-antichymotrypsin, antithrombin III, alpha 2-antiplasmi

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.6.3695

Effect of the Z mutation on the physical and inhibitory properties of alpha 1-antitrypsin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.6.3695

The control of neutrophil chemotaxis by inhibitors of cathepsin G and chymotrypsin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.6.3695

Identification of lysines within alpha 1-antichymotrypsin important for DNA binding. An unusual combination of DNA-binding elements

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.6.3695

Structural alterations in alpha 1-antichymotrypsin from normal and acute phase human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.6.3695

The microheterogeneity of desialylated alpha 1-antichymotrypsin: the occurrence of two amino-terminal isoforms, one lacking a His-Pro dipeptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.6.3695

[Characterization of alpha-1-X-glycoprotein as chymotrypsin inhibitor of human plasma]

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.6.3695

Purification and characterization of alpha 1-antichymotrypsin from human pleural fluid and human serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.6.3695

Conformation of the reactive site loop of alpha 1-proteinase inhibitor probed by limited proteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.6.3695

21 January 2018

Identifiers

DOI

10.1074/JBC.273.6.3695

1 reference

14 March 2018

1 reference

14 March 2018